CIK 1440771
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 91.35% | 54 |
| Unclassified | 4.05% | 4 |
| Health Care Equipment & Supplies | 3.15% | 5 |
| Life Sciences Tools & Services | 0.85% | 2 |
| Chemicals | 0.60% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | VSTM | Verastem, Inc. | Health Care | 15.39% |
| 2 | TENX | TENAX THERAPEUTICS, INC. | Health Care | 13.72% |
| 3 | EOLS | Evolus, Inc. | Health Care | 6.36% |
| 4 | ADMA | ADMA BIOLOGICS, INC. | Health Care | 5.86% |
| 5 | CAMP | Camp4 Therapeutics Corp | Health Care | 5.39% |
| 6 | NKTR | NEKTAR THERAPEUTICS | Health Care | 5.38% |
| 7 | ZVRA | ZEVRA THERAPEUTICS, INC. | Health Care | 3.93% |
| 8 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Health Care | 3.17% |
| 9 | ABEO | ABEONA THERAPEUTICS INC. | Health Care | 2.94% |
| 10 | KZIA | KAZIA THERAPEUTICS LTD | Health Care | 2.26% |
62/66 names classified · sector 96.0% of weight · industry 96.0% · mkt cap 93.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 96.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 15% of book weight classified — the grid is NOT representative of the whole book.
Classified: 14.7% of book weight (5/66 names) · unclassified 85.3%: VSTM, TENX, EOLS, CAMP, NKTR, CRBP, KZIA, ANTX, SLGL, AYTU +51 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | VSTMVERASTEM INC | 3,302,300 | $18M | 15.4% | ADD 21% |
| 2 | TENXTENAX THERAPEUTICS INC | 975,200 | $16M | 13.7% | ADD 8106% |
| 3 | EOLSEVOLUS INC | 1,759,091 | $7M | 6.4% | ADD 8% |
| 4 | ADMAADMA BIOLOGICS INC | 740,000 | $7M | 5.9% | HOLD |
| 5 | CAMPCAMP4 THERAPEUTICS CORP | 1,389,622 | $6M | 5.4% | ADD 507% |
| 6 | NKTRNEKTAR THERAPEUTICS | 85,000 | $6M | 5.4% | HOLD |
| 7 | ZVRAZEVRA THERAPEUTICS INC | 480,000 | $4M | 3.9% | TRIM −16% |
| 8 | CRBPCORBUS PHARMACEUTICALS HLDGS | 383,462 | $4M | 3.2% | HOLD |
| 9 | ABEOABEONA THERAPEUTICS INC | 746,587 | $3M | 2.9% | ADD 5% |
| 10 | KZIAKAZIA THERAPEUTICS LTD | 345,179 | $3M | 2.3% | TRIM −25% |
| 11 | ANTXAN2 THERAPEUTICS INC | 713,845 | $2M | 2.1% | ADD 14% |
| 12 | SLGLSOL GEL TECHNOLOGIES | 27,778 | $2M | 1.9% | NEW |
| 13 | XOMAXOMA ROYALTY CORPORATION | 69,500 | $2M | 1.9% | TRIM −40% |
| 14 | AYTUAYTU BIOPHARMA INC | 792,289 | $2M | 1.9% | TRIM −3% |
| 15 | CRISCURIS INC | 3,726,406 | $2M | 1.8% | ADD 6179% |
| 16 | TELATELA BIO INC | 2,617,252 | $2M | 1.4% | ADD 11% |
| 17 | IKTINHIBIKASE THERAPEUTICS INC | 957,202 | $2M | 1.4% | TRIM −59% |
| 18 | CBIOCRESCENT BIOPHARMA INC. | 85,000 | $2M | 1.4% | TRIM −3% |
| 19 | ACETADICET BIO INC | 221,955 | $2M | 1.3% | HOLD |
| 20 | XFORX4 PHARMACEUTICALS INC | 335,309 | $1M | 1.2% | TRIM −44% |
| 21 | OKYOOKYO PHARMA LTD | 850,000 | $1M | 1.2% | NEW |
| 22 | HRTXHERON THERAPEUTICS INC | 1,402,191 | $1M | 1.0% | ADD 13% |
| 23 | LUNGPULMONX CORP | 768,288 | $991,092 | 0.9% | ADD 58% |
| 24 | INABIN8BIO INC | 663,412 | $981,850 | 0.9% | ADD 302% |
| 25 | SRZNSURROZEN INC | 33,005 | $961,436 | 0.8% | TRIM −71% |
| 26 | CTMXCYTOMX THERAPEUTICS INC. | 200,000 | $940,000 | 0.8% | NEW |
| 27 | PMVPPMV PHARMACEUTICALS INC | 708,102 | $878,046 | 0.8% | TRIM −38% |
| 28 | BIOABIOAGE LABS INC | 50,000 | $874,500 | 0.8% | ADD 11% |
| 29 | CNTBCONNECT BIOPHARMA HLDGS LTD | 310,000 | $812,200 | 0.7% | NEW |
| 30 | RADXRadiopharm Theranostics Ltd | 51,000,000 | $738,977 | 0.6% | HOLD |
| 31 | MXCTMAXCYTE INC | 1,004,673 | $705,783 | 0.6% | ADD 114% |
| 32 | CDXSCODEXIS INC | 417,994 | $681,330 | 0.6% | ADD 63% |
| 33 | BOLDBOUNDLESS BIO INC | 597,682 | $657,450 | 0.6% | TRIM −16% |
| 34 | HELPCYBIN INC | 134,060 | $643,488 | 0.6% | TRIM −61% |
| 35 | ZNTLZENTALIS PHARMACEUTICALS INC | 269,100 | $629,694 | 0.6% | TRIM −42% |
| 36 | KTTAPasithea Therapeutics Corp | 831,301 | $616,659 | 0.5% | ADD 202% |
| 37 | MSLESATELLOS BIOSCIENCE INC | 100,000 | $563,000 | 0.5% | NEW |
| 38 | PHATPHATHOM PHARMACEUTICALS INC | 50,010 | $555,611 | 0.5% | NEW |
| 39 | OKURONKURE THERAPEUTICS INC | 132,578 | $548,873 | 0.5% | NEW |
| 40 | XLOXILIO THERAPEUTICS INC | 64,162 | $539,602 | 0.5% | NEW |
| 41 | VRCAVERRICA PHARMACEUTICALS INC | 99,735 | $527,598 | 0.5% | TRIM −72% |
| 42 | CADLCANDEL THERAPEUTICS INC | 102,500 | $502,250 | 0.4% | NEW |
| 43 | POCIPRECISION OPTICS CORP INC MA | 100,000 | $439,000 | 0.4% | NEW |
| 44 | QNRXQUOIN PHARMACEUTICALS LTD | 53,460 | $352,836 | 0.3% | TRIM −32% |
| 45 | ESTAESTABLISHMENT LABS HLDGS INC | 6,000 | $340,680 | 0.3% | NEW |
| 46 | UPBUPSTREAM BIO INC | 35,000 | $315,000 | 0.3% | NEW |
| 47 | IRDOPUS GENETICS INC | 68,688 | $312,530 | 0.3% | NEW |
| 48 | ARVNARVINAS INC | 27,500 | $291,500 | 0.3% | NEW |
| 49 | PLRXPLIANT THERAPEUTICS INC | 224,650 | $283,059 | 0.2% | TRIM −2% |
| 50 | JANXJANUX THERAPEUTICS INC | 20,000 | $278,000 | 0.2% | HOLD |
| 51 | OABIOMNIAB INC | 164,045 | $257,551 | 0.2% | TRIM −77% |
| 52 | XERSXERIS BIOPHARMA HOLDINGS INC | 40,030 | $232,174 | 0.2% | NEW |
| 53 | CGENCOMPUGEN LTD | 104,300 | $222,159 | 0.2% | TRIM −66% |
| 54 | NMRANEUMORA THERAPEUTICS INC. | 100,000 | $195,000 | 0.2% | NEW |
| 55 | SABSSAB BIOTHERAPEUTICS INC | 50,000 | $191,500 | 0.2% | NEW |
| 56 | SIBNSI-BONE INC | 14,964 | $188,995 | 0.2% | NEW |
| 57 | EDSAEDESA BIOTECH INC | 30,000 | $156,900 | 0.1% | TRIM −96% |
| 58 | CNSPCNS PHARMACEUTICALS INC | 61,000 | $145,790 | 0.1% | ADD 25% |
| 59 | PCSAPROCESSA PHARMACEUTICALS INC | 55,000 | $138,875 | 0.1% | ADD 346% |
| 60 | CABACABALETTA BIO INC | 50,000 | $134,500 | 0.1% | TRIM −71% |
| 61 | KLRSKALARIS THERAPEUTICS INC | 20,400 | $117,708 | 0.1% | NEW |
| 62 | ELDNELEDON PHARMACEUTICALS INC | 35,000 | $107,800 | 0.1% | TRIM −96% |
| 63 | OVIDOVID THERAPEUTICS INC | 40,000 | $88,800 | 0.1% | TRIM −61% |
| 64 | EVAXEVAXION AS SPONSORED ADS | 19,713 | $73,332 | 0.1% | HOLD |
| 65 | MNKDMANNKIND CORP | 16,300 | $39,935 | 0.0% | TRIM −81% |
| 66 | BCABBIOATLA INC | 65,387 | $10,527 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| VSTMVERASTEM INC | 870K | 613K | 1.4M | 2.7M | 2.7M | 3.3M | $18M |
| TENXTENAX THERAPEUTICS INC | — | — | — | — | 12K | 975K | $16M |
| EOLSEVOLUS INC | 1.3M | 1.1M | 917K | 1.5M | 1.6M | 1.8M | $7M |
| ADMAADMA BIOLOGICS INC | 1.2M | 810K | 750K | 739K | 740K | 740K | $7M |
| CAMPCAMP4 THERAPEUTICS CORP | — | — | — | — | 229K | 1.4M | $6M |
| NKTRNEKTAR THERAPEUTICS | — | — | 50K | 85K | 85K | 85K | $6M |
| ZVRAZEVRA THERAPEUTICS INC | 598K | 650K | 776K | 810K | 569K | 480K | $4M |
| CRBPCORBUS PHARMACEUTICALS HLDGS | — | 35K | — | — | 390K | 383K | $4M |
| ABEOABEONA THERAPEUTICS INC | — | — | 45K | 451K | 710K | 747K | $3M |
| KZIAKAZIA THERAPEUTICS LTD | — | — | — | — | 460K | 345K | $3M |
| ANTXAN2 THERAPEUTICS INC | 197K | — | 544K | 564K | 628K | 714K | $2M |
| SLGLSOL GEL TECHNOLOGIES | — | — | — | — | — | 28K | $2M |
| XOMAXOMA ROYALTY CORPORATION | 126K | 130K | 152K | 115K | 115K | 70K | $2M |
| AYTUAYTU BIOPHARMA INC | 408K | 464K | 813K | 892K | 814K | 792K | $2M |
| CRISCURIS INC | — | — | — | — | 59K | 3.7M | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
